Important Note: Redirection of Services to ChiCTR
We would like to inform you that the Clinical Trial Registry page will discontinue the function of updating trial information directly on this platform. However, you will still be able to view the existing registration details. For any updates to trial information, you can use the China Clinical Trial Registry (ChiCTR) directly at https://www.chictr.org.cn. This change will be fully implemented by 2024-Aug-05. Thank you for your attention.
CUHK_CCT00188
2009-07-27
Prospective
NIL
Department Funding [Department of Ophthalmology & Visual Sciences, CUHK]
NIL
NIL
Miss Joyce Kung
Department of Ophthalmology & Visual Sciences, CUHK, 3/F, Hong Kong Eye Hospital, 147K Argyle Street
Tel: 2762 3134;
Email: joycekung@cuhk.edu.hk
Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong
Dr. Leung Kai Shun Christopher
Department of Ophthalmology & Visual Sciences, CUHK, 3/F, Hong Kong Eye Hospital, 147K Argyle Street
Tel: 2762 3080;
Email: cksleung@cuhk.edu.hk
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong
Evaluation of Selective Laser Trabeculoplasty for Intraocular Pressure Lowering in Chinese Eyes – A pilot study
Evaluation of Selective Laser Trabeculoplasty for Intraocular Pressure Lowering in Chinese Eyes – A pilot study
Intraocular pressure lowering effect of selective laser trabeculoplasty
Hong Kong
Yes
2009-06-29
Glaucoma and ocular hypertension
Procedure
selective laser trabeculoplasty
procedure duration - 15 minutes
none
Inclusion Criteria
-A diagnosis of normal tension glaucoma, primary open angle glaucoma, primary angle closure glaucoma or steroid induced ocular hypertension / glaucoma
-Older than 18 years of age
-Able to give informed consent
Exclusion Criteria
- Significant cataract rendering visual field testing or optic disc imaging not technically possible
- Previous SLT or ALT
- Participation in another therapeutic drug study within the last 30 days
- Severe health problems precluding follow-up such as end-stage heart disease, kidney disease, respiratory disease, or cancer.
18
None set
Both Male and Female
Interventional
Non-randomized
Uncontrolled
Open label
Single group
2009-07-31
200
Unknown
Intraocular pressure at 1 week, 1 month, 3 months, 6 months, 1 year
Visual field progression and Retinal nerve fiber layer progression at 1 year
2015-06-23
ChiCTR-TRC-09000731
2010-05-04
Yes
NIL
|
|
|
|
|
---|---|---|---|---|
No documents yet. |